Equinox药业控股减持RAMEDA股份至8.348% 套现11.2亿埃镑

投资观察
Mar 15

埃及交易所3月15日公告显示,Equinox Pharma Holding Limited通过大宗交易减持RAMEDA公司2.2亿股股份,交易总额达11.2亿埃镑(约合1.12亿英镑)。此次减持后,该投资机构对RAMEDA的持股比例从19.348%显著降至8.348%,减持幅度高达11个百分点。

本次股权变动引发市场对医药板块资金流向的关注。分析人士指出,机构持股比例的大幅调整可能影响RAMEDA公司治理结构,同时也反映出投资者对埃及医药行业估值水平的重新评估。

根据交易所披露的实时数据,该笔交易于格林尼治时间3月15日06:59完成。RAMEDA公司股票代码为RMDA.CA,近期股价波动备受投资者关注。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10